| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microfilament motor activity | 5.25e-12 | 38 | 143 | 9 | GO:0000146 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 DYNC2H1 MYH7B KIF19 MYH15 DNAH8 | 5.09e-11 | 118 | 143 | 12 | GO:0003774 |
| GeneOntologyMolecularFunction | actin filament binding | TPM3 MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH7B SPTAN1 SVIL MACF1 MYH15 | 9.77e-09 | 227 | 143 | 13 | GO:0051015 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 BRIP1 WAPL DYNC2H1 MYH7B SMC1A HELB DHX15 AFG3L2 KIF19 MACF1 MYH15 DNAH8 | 8.49e-08 | 614 | 143 | 19 | GO:0140657 |
| GeneOntologyMolecularFunction | calmodulin binding | 8.49e-07 | 230 | 143 | 11 | GO:0005516 | |
| GeneOntologyMolecularFunction | actin binding | TPM3 MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH7B SPTAN1 KLHL20 SVIL SYNE2 MACF1 MYH15 | 1.85e-06 | 479 | 143 | 15 | GO:0003779 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TPM3 MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH7B SPTAN1 CEP290 ARFGEF1 KLHL20 NDC80 SVIL SYNE2 KIF19 IRAG2 KIRREL1 MACF1 MYH15 SKA1 | 1.15e-05 | 1099 | 143 | 22 | GO:0008092 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYH3 MYH4 MYH7 MYH8 BRIP1 DYNC2H1 SMC1A HELB DHX15 AFG3L2 KIF19 MACF1 DNAH8 | 1.77e-05 | 441 | 143 | 13 | GO:0016887 |
| GeneOntologyBiologicalProcess | muscle filament sliding | 3.35e-10 | 15 | 135 | 6 | GO:0030049 | |
| GeneOntologyBiologicalProcess | actin-myosin filament sliding | 1.22e-09 | 18 | 135 | 6 | GO:0033275 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 6.69e-08 | 153 | 135 | 10 | GO:0030048 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 1.56e-07 | 127 | 135 | 9 | GO:0070252 | |
| GeneOntologyBiologicalProcess | actin filament-based process | TPM3 STARD13 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 DSP MYH7B SPTAN1 ASAP3 ARFGEF1 TSC1 CIT SVIL SYNE2 KIRREL1 PARD3 | 7.83e-06 | 912 | 135 | 19 | GO:0030029 |
| GeneOntologyBiologicalProcess | muscle contraction | 6.63e-05 | 400 | 135 | 11 | GO:0006936 | |
| GeneOntologyBiologicalProcess | head development | MYH3 DYNC2H1 CEP290 CCDC85C TSC1 CFAP43 PLXNB2 HOXA2 RAB3GAP1 ALDH1A2 UBE3A GLI2 SYNE2 ANKRD11 TAF1 HYDIN PCNT | 1.07e-04 | 919 | 135 | 17 | GO:0060322 |
| GeneOntologyBiologicalProcess | protein autoubiquitination | 1.60e-04 | 78 | 135 | 5 | GO:0051865 | |
| GeneOntologyBiologicalProcess | microtubule-based process | RANBP1 FLOT2 DYNC2H1 SMC1A CEP290 TUBA3E CFAP43 DZIP1 TEKT5 NDC80 SYNE2 KIF19 MACF1 PARD3 SKA1 DNAH8 HYDIN PCNT | 1.88e-04 | 1058 | 135 | 18 | GO:0007017 |
| GeneOntologyCellularComponent | myosin filament | 3.19e-14 | 25 | 137 | 9 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 1.06e-13 | 28 | 137 | 9 | GO:0016460 | |
| GeneOntologyCellularComponent | muscle myosin complex | 4.85e-12 | 16 | 137 | 7 | GO:0005859 | |
| GeneOntologyCellularComponent | myosin complex | 1.63e-10 | 59 | 137 | 9 | GO:0016459 | |
| GeneOntologyCellularComponent | myofibril | TPM3 MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH7B SPTAN1 SVIL SYNE2 MYH15 | 3.06e-08 | 273 | 137 | 13 | GO:0030016 |
| GeneOntologyCellularComponent | actin cytoskeleton | TPM3 MYH1 MYH2 MYH3 MYH4 ARHGAP32 FLOT2 MYH6 MYH7 MYH8 MYH7B SPTAN1 TSC1 CIT KLHL20 SVIL MACF1 MYH15 | 4.32e-08 | 576 | 137 | 18 | GO:0015629 |
| GeneOntologyCellularComponent | supramolecular fiber | TPM3 MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 DCDC2C DSP DYNC2H1 MYH7B SPTAN1 TUBA3E TSC1 TEKT5 KRT73 PARP4 SVIL SYNE2 KIF19 MACF1 MYH15 SKA1 DNAH8 PCNT | 4.37e-08 | 1179 | 137 | 26 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | TPM3 MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 DCDC2C DSP DYNC2H1 MYH7B SPTAN1 TUBA3E TSC1 TEKT5 KRT73 PARP4 SVIL SYNE2 KIF19 MACF1 MYH15 SKA1 DNAH8 PCNT | 5.00e-08 | 1187 | 137 | 26 | GO:0099081 |
| GeneOntologyCellularComponent | contractile muscle fiber | TPM3 MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH7B SPTAN1 SVIL SYNE2 MYH15 | 6.21e-08 | 290 | 137 | 13 | GO:0043292 |
| GeneOntologyCellularComponent | sarcomere | 5.86e-06 | 249 | 137 | 10 | GO:0030017 | |
| GeneOntologyCellularComponent | cytoplasmic region | RANBP1 FLOT2 DYNC2H1 CFAP43 TEKT5 GUCY1B1 GLI2 KIF19 DNAH8 HYDIN | 1.34e-04 | 360 | 137 | 10 | GO:0099568 |
| GeneOntologyCellularComponent | cell cortex | TPM3 MYH2 ARHGAP32 FLOT2 SPTAN1 TSC1 GUCY1B1 MACF1 PARD3 SPINK5 | 1.71e-04 | 371 | 137 | 10 | GO:0005938 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 2.48e-04 | 317 | 137 | 9 | GO:0032838 | |
| GeneOntologyCellularComponent | axoneme | 4.38e-04 | 207 | 137 | 7 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 4.51e-04 | 208 | 137 | 7 | GO:0097014 | |
| GeneOntologyCellularComponent | microtubule | DCDC2C DYNC2H1 TUBA3E TEKT5 PARP4 SVIL KIF19 MACF1 SKA1 DNAH8 PCNT | 7.85e-04 | 533 | 137 | 11 | GO:0005874 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | TPM3 DCDC2C DSP DYNC2H1 TUBA3E TSC1 TEKT5 KRT73 PARP4 SVIL KIF19 MACF1 SKA1 DNAH8 PCNT | 8.29e-04 | 899 | 137 | 15 | GO:0099513 |
| GeneOntologyCellularComponent | centriolar satellite | 1.56e-03 | 128 | 137 | 5 | GO:0034451 | |
| GeneOntologyCellularComponent | peptidase complex | 1.85e-03 | 133 | 137 | 5 | GO:1905368 | |
| GeneOntologyCellularComponent | cell division site | 1.90e-03 | 80 | 137 | 4 | GO:0032153 | |
| GeneOntologyCellularComponent | cilium | DCDC2C FSIP1 DYNC2H1 CEP290 CCDC178 CFAP43 DZIP1 TEKT5 GLI2 KIF19 USP48 DNAH8 HYDIN PCNT | 2.33e-03 | 898 | 137 | 14 | GO:0005929 |
| GeneOntologyCellularComponent | motile cilium | 2.40e-03 | 355 | 137 | 8 | GO:0031514 | |
| GeneOntologyCellularComponent | microtubule organizing center | RANBP1 RAPGEF6 DCDC2C CEP290 CCDC178 DZIP1 ECPAS LUZP1 UBN1 NDC80 KIAA1217 IRAG2 SKA1 PCNT | 2.87e-03 | 919 | 137 | 14 | GO:0005815 |
| MousePheno | abnormal brain development | RANBP1 DSP DYNC2H1 SPTAN1 CEP290 ZNF521 CCDC85C CFAP43 PLXNB2 F3 LUZP1 HOXA2 GLI2 KIF19 SMARCC1 PARD3 HYDIN PCNT | 1.98e-06 | 638 | 109 | 18 | MP:0000913 |
| MousePheno | abnormal brain ventricular system morphology | SPTAN1 CEP290 ARFGEF1 CCDC85C CFAP43 PLXNB2 LUZP1 GLI2 KIF19 SMARCC1 PRDM16 HYDIN PCNT | 1.14e-05 | 393 | 109 | 13 | MP:0002200 |
| MousePheno | abnormal brain ventricle morphology | SPTAN1 ARFGEF1 CCDC85C CFAP43 PLXNB2 LUZP1 KIF19 SMARCC1 PRDM16 HYDIN PCNT | 1.41e-05 | 286 | 109 | 11 | MP:0000822 |
| MousePheno | abnormal nervous system development | RANBP1 ARHGAP32 DSP DYNC2H1 SPTAN1 CEP290 ZNF521 ARFGEF1 CCDC85C TSC1 CFAP43 DZIP1 PLXNB2 F3 LUZP1 HOXA2 ALDH1A2 GLI2 KIF19 SMARCC1 PARD3 HYDIN PCNT | 8.59e-05 | 1257 | 109 | 23 | MP:0003861 |
| MousePheno | abnormal hindbrain morphology | RANBP1 CEP290 ZNF521 ARFGEF1 CCDC85C PLXNB2 CIT LUZP1 HOXA2 UBE3A GLI2 AFG3L2 HYDIN | 1.01e-04 | 485 | 109 | 13 | MP:0000841 |
| MousePheno | abnormal metencephalon morphology | CEP290 ZNF521 ARFGEF1 CCDC85C PLXNB2 CIT LUZP1 HOXA2 UBE3A GLI2 AFG3L2 HYDIN | 1.04e-04 | 420 | 109 | 12 | MP:0000847 |
| Domain | Myosin_N | 1.98e-16 | 15 | 135 | 9 | PF02736 | |
| Domain | Myosin_N | 1.98e-16 | 15 | 135 | 9 | IPR004009 | |
| Domain | Myosin_tail_1 | 1.89e-15 | 18 | 135 | 9 | PF01576 | |
| Domain | Myosin_tail | 1.89e-15 | 18 | 135 | 9 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 3.57e-15 | 19 | 135 | 9 | IPR027401 | |
| Domain | - | 3.57e-15 | 19 | 135 | 9 | 4.10.270.10 | |
| Domain | Myosin_head_motor_dom | 5.61e-12 | 38 | 135 | 9 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 5.61e-12 | 38 | 135 | 9 | PS51456 | |
| Domain | Myosin_head | 5.61e-12 | 38 | 135 | 9 | PF00063 | |
| Domain | MYSc | 5.61e-12 | 38 | 135 | 9 | SM00242 | |
| Domain | IQ | 2.37e-08 | 93 | 135 | 9 | PS50096 | |
| Domain | IQ | 1.25e-07 | 81 | 135 | 8 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 2.85e-07 | 90 | 135 | 8 | IPR000048 | |
| Domain | P-loop_NTPase | GTPBP4 MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 BRIP1 DYNC2H1 MYH7B SMC1A IFI44 HELB DHX15 AFG3L2 KIF19 MYH15 DNAH8 HYDIN | 3.00e-06 | 848 | 135 | 20 | IPR027417 |
| Domain | IQ | 1.24e-05 | 71 | 135 | 6 | PF00612 | |
| Domain | Spectrin_repeat | 5.39e-05 | 29 | 135 | 4 | IPR002017 | |
| Domain | SPEC | 8.02e-05 | 32 | 135 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 8.02e-05 | 32 | 135 | 4 | IPR018159 | |
| Domain | Spectrin | 5.88e-04 | 23 | 135 | 3 | PF00435 | |
| Domain | - | 7.63e-04 | 6 | 135 | 2 | 3.90.1290.10 | |
| Domain | SANT_dom | 8.50e-04 | 26 | 135 | 3 | IPR017884 | |
| Domain | SANT | 1.06e-03 | 28 | 135 | 3 | PS51293 | |
| Domain | Plectin | 1.06e-03 | 7 | 135 | 2 | PF00681 | |
| Domain | Plectin_repeat | 1.06e-03 | 7 | 135 | 2 | IPR001101 | |
| Domain | PLEC | 1.06e-03 | 7 | 135 | 2 | SM00250 | |
| Domain | DHC_N1 | 1.41e-03 | 8 | 135 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.41e-03 | 8 | 135 | 2 | IPR013594 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 6.29e-11 | 70 | 101 | 10 | M12294 | |
| Pathway | KEGG_TIGHT_JUNCTION | 2.48e-09 | 132 | 101 | 11 | M11355 | |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 1.10e-04 | 35 | 101 | 4 | MM15005 | |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 1.23e-04 | 36 | 101 | 4 | M18647 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 1.43e-04 | 70 | 101 | 5 | M41806 | |
| Pathway | WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY | 1.52e-04 | 38 | 101 | 4 | M39549 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 1.86e-04 | 74 | 101 | 5 | M41807 | |
| Pubmed | 2.19e-17 | 7 | 148 | 7 | 16819597 | ||
| Pubmed | TPM3 STARD13 MYH1 MYH2 MYH3 MYH4 RANBP1 MYH6 MYH7 MYH8 ERCC5 DSP MYH7B PPFIA4 SPTAN1 PSMD1 FAM114A2 FAM47B TSC1 CAGE1 PABPC5 LUZP1 KRT73 SYNE2 EIF4G1 SMARCC1 MACF1 MYH15 EEA1 UQCRH TOP1MT DNAH8 OBI1 GOLGB1 PCNT | 3.30e-17 | 1442 | 148 | 35 | 35575683 | |
| Pubmed | 5.36e-15 | 6 | 148 | 6 | 1728586 | ||
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 5.36e-15 | 6 | 148 | 6 | 10588881 | |
| Pubmed | 3.74e-14 | 7 | 148 | 6 | 35210422 | ||
| Pubmed | 1.49e-13 | 8 | 148 | 6 | 3864153 | ||
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 1.30e-12 | 5 | 148 | 5 | 3829126 | |
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 1.30e-12 | 5 | 148 | 5 | 12919077 | |
| Pubmed | 1.30e-12 | 5 | 148 | 5 | 6196357 | ||
| Pubmed | TPM3 MYH3 MYH7 MYH8 ZFAT UACA DSP SMC1A PSMD1 DZIP1 DHX15 PARP4 SYNE2 AFG3L2 MACF1 TAF1 PARD3 MRFAP1L1 | 5.09e-12 | 497 | 148 | 18 | 23414517 | |
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 7.80e-12 | 6 | 148 | 5 | 10077619 | |
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 8.98e-12 | 13 | 148 | 6 | 8404542 | |
| Pubmed | 1.57e-11 | 14 | 148 | 6 | 27184118 | ||
| Pubmed | ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism. | 2.72e-11 | 7 | 148 | 5 | 29758057 | |
| Pubmed | A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. | 4.15e-11 | 16 | 148 | 6 | 19922871 | |
| Pubmed | 3.15e-10 | 4 | 148 | 4 | 20357587 | ||
| Pubmed | 3.15e-10 | 4 | 148 | 4 | 1985022 | ||
| Pubmed | 3.15e-10 | 4 | 148 | 4 | 19948655 | ||
| Pubmed | 3.78e-10 | 22 | 148 | 6 | 24301466 | ||
| Pubmed | Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers. | 5.90e-10 | 11 | 148 | 5 | 16024798 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TPM3 BRIP1 RAPGEF6 WAPL ERCC5 UACA ARID4A DSP SMC1A SPTAN1 CAST PSMD1 ECPAS UBN1 PRICKLE3 SVIL EIF4G1 SMARCC1 PARD3 | 9.26e-10 | 774 | 148 | 19 | 15302935 |
| Pubmed | 2.53e-09 | 14 | 148 | 5 | 24938781 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TPM3 STARD13 GTPBP4 RANBP1 WAPL MIS18BP1 DSP SMC1A SPTAN1 LRSAM1 PSMD1 TSC1 IPO4 LUZP1 DHX15 RAB3GAP1 UBN1 UBE3A AFG3L2 EIF4G1 SMARCC1 MACF1 PARD3 EIF3M | 3.18e-09 | 1353 | 148 | 24 | 29467282 |
| Pubmed | 3.62e-09 | 31 | 148 | 6 | 21985497 | ||
| Pubmed | Six homeoproteins and a Iinc-RNA at the fast MYH locus lock fast myofiber terminal phenotype. | 3.78e-09 | 15 | 148 | 5 | 24852826 | |
| Pubmed | ARHGAP32 FLOT2 RAPGEF6 UACA DZIP1 PLXNB2 ADCY9 KIAA1217 AFG3L2 KIRREL1 MACF1 PARD3 DEPDC1B GOLGB1 | 3.96e-09 | 421 | 148 | 14 | 36976175 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MIS18BP1 DSP DYNC2H1 LRSAM1 TSC1 IPO4 LUZP1 ALDH1A2 UBN1 NDC80 KIAA1217 AFG3L2 MACF1 OBI1 GOLGB1 PCNT | 5.09e-09 | 588 | 148 | 16 | 38580884 |
| Pubmed | Myosin heavy chain-embryonic regulates skeletal muscle differentiation during mammalian development. | 5.40e-09 | 33 | 148 | 6 | 32094117 | |
| Pubmed | 5.49e-09 | 58 | 148 | 7 | 21884692 | ||
| Pubmed | GTPBP4 ARHGAP32 UACA SPTAN1 TSC1 IPO4 CIT TMEM132B LUZP1 UBE3A KIAA1217 SVIL SYNE2 EIF4G1 SMARCC1 MACF1 CDC73 PARD3 GOLGB1 PCNT | 5.57e-09 | 963 | 148 | 20 | 28671696 | |
| Pubmed | 7.74e-09 | 17 | 148 | 5 | 16124007 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH1 MYH2 MYH3 MYH4 RANBP1 MYH6 MYH7 MYH8 DSP MYH7B SPTAN1 CAST PSMD1 PABPC5 IPO4 EIF3M | 1.94e-08 | 647 | 148 | 16 | 26618866 |
| Pubmed | A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning. | 2.17e-08 | 8 | 148 | 4 | 14667415 | |
| Pubmed | 2.17e-08 | 8 | 148 | 4 | 26993635 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | TPM3 GTPBP4 RANBP1 FLOT2 DSP SMC1A SPTAN1 PABPC5 CIT NDC80 KIAA1217 EIF4G1 SMARCC1 MACF1 EEA1 EIF3M GOLGB1 PCNT | 2.43e-08 | 847 | 148 | 18 | 35235311 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | TPM3 ARHGAP32 FLOT2 MIS18BP1 DSP CEP290 CAST CCDC85C UBAP1 TSC1 ECPAS LUZP1 ALDH1A2 NDC80 KIAA1217 SVIL NFX1 PCNT | 2.70e-08 | 853 | 148 | 18 | 28718761 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ARHGAP32 FLOT2 RAPGEF6 DSP SPTAN1 CCDC85C DZIP1 LUZP1 KIAA1217 SVIL SYNE2 EIF4G1 ANKRD11 MACF1 PARD3 OBI1 DEPDC1B GOLGB1 | 3.11e-08 | 861 | 148 | 18 | 36931259 |
| Pubmed | DENND5B BRIP1 DSP FSIP1 ASAP3 PSMD1 DHX15 PTPRA CARD9 SYNE2 PCNT | 3.27e-08 | 277 | 148 | 11 | 30745168 | |
| Pubmed | 3.90e-08 | 9 | 148 | 4 | 31960486 | ||
| Pubmed | HOXA5 plays tissue-specific roles in the developing respiratory system. | 4.37e-08 | 46 | 148 | 6 | 28827394 | |
| Pubmed | 4.38e-08 | 118 | 148 | 8 | 30979931 | ||
| Pubmed | FLOT2 SPTAN1 LUZP1 UBE3A KIAA1217 SVIL EIF4G1 MACF1 CDC73 EEA1 GOLGB1 PCNT | 5.21e-08 | 360 | 148 | 12 | 33111431 | |
| Pubmed | The expression of myosin genes in developing skeletal muscle in the mouse embryo. | 6.48e-08 | 10 | 148 | 4 | 2211821 | |
| Pubmed | Acceleration of somitic myogenesis in embryos of myogenin promoter-MRF4 transgenic mice. | 6.48e-08 | 10 | 148 | 4 | 8950513 | |
| Pubmed | Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation. | 7.55e-08 | 3 | 148 | 3 | 26059207 | |
| Pubmed | Mouse embryonic stem cells express the cardiac myosin heavy chain genes during development in vitro. | 7.55e-08 | 3 | 148 | 3 | 1694848 | |
| Pubmed | Identification of three developmentally controlled isoforms of human myosin heavy chains. | 7.55e-08 | 3 | 148 | 3 | 1691980 | |
| Pubmed | 7.55e-08 | 3 | 148 | 3 | 21470888 | ||
| Pubmed | Myosin heavy chain gene expression in mouse embryoid bodies. An in vitro developmental study. | 7.55e-08 | 3 | 148 | 3 | 1939265 | |
| Pubmed | Structural and developmental analysis of two linked myosin heavy chain genes. | 7.55e-08 | 3 | 148 | 3 | 1371481 | |
| Pubmed | GTPBP4 FLOT2 UACA DYNC2H1 SPTAN1 RRP8 DZIP1 IPO4 PLXNB2 ADCY9 DNAJC2 RAB3GAP1 SARS1 SYNE2 AFG3L2 ANKRD11 KIRREL1 MACF1 PARD3 USP48 DEPDC1B GOLGB1 PCNT | 8.58e-08 | 1487 | 148 | 23 | 33957083 | |
| Pubmed | 1.02e-07 | 11 | 148 | 4 | 18310078 | ||
| Pubmed | 1.02e-07 | 11 | 148 | 4 | 8136524 | ||
| Pubmed | The histone code reader Spin1 controls skeletal muscle development. | 1.02e-07 | 11 | 148 | 4 | 29168801 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPM3 GTPBP4 RANBP1 FLOT2 RAPGEF6 WAPL DSP CAST CCDC85C FAM114A2 TSC1 ALDH1A2 KIAA1217 AFG3L2 MACF1 DEPDC1B GOLGB1 PCNT | 1.05e-07 | 934 | 148 | 18 | 33916271 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | RANBP1 ARHGAP32 UACA SPTAN1 CAST CCDC85C ADCY9 LUZP1 KIAA1217 SVIL EIF4G1 MACF1 PARD3 GOLGB1 | 1.53e-07 | 565 | 148 | 14 | 25468996 |
| Pubmed | ARHGAP32 MIS18BP1 CCDC85C KIAA1217 SVIL NFX1 KIRREL1 MACF1 PARD3 GOLGB1 | 2.10e-07 | 263 | 148 | 10 | 34702444 | |
| Pubmed | 2.18e-07 | 13 | 148 | 4 | 8948582 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | GTPBP4 WAPL DSP SMC1A SPTAN1 PSMD1 PARP4 UBN1 NDC80 MACF1 CDC73 USP48 GOLGB1 PCNT | 2.19e-07 | 582 | 148 | 14 | 20467437 |
| Pubmed | 2.39e-07 | 32 | 148 | 5 | 33732701 | ||
| Pubmed | Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle. | 3.01e-07 | 4 | 148 | 3 | 11029314 | |
| Pubmed | Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling. | 3.01e-07 | 4 | 148 | 3 | 18417546 | |
| Pubmed | 3.01e-07 | 4 | 148 | 3 | 10388558 | ||
| Pubmed | 3.01e-07 | 4 | 148 | 3 | 11023856 | ||
| Pubmed | 3.05e-07 | 14 | 148 | 4 | 33742095 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TPM3 GTPBP4 FLOT2 DSP SMC1A CEP290 PSMD1 PLXNB2 CIT DHX15 SVIL SYNE2 AFG3L2 EIF4G1 MACF1 EEA1 GOLGB1 PCNT | 4.03e-07 | 1024 | 148 | 18 | 24711643 |
| Pubmed | 4.14e-07 | 15 | 148 | 4 | 28737171 | ||
| Pubmed | 5.51e-07 | 16 | 148 | 4 | 16494860 | ||
| Pubmed | 5.51e-07 | 16 | 148 | 4 | 22090424 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | TPM3 GTPBP4 ERCC5 DSP SMC1A SPTAN1 CAST PSMD1 TSC1 DNAJC2 DHX15 SARS1 SYNE2 AFG3L2 EIF4G1 SMARCC1 MACF1 CDC73 EIF3M GOLGB1 SPINK5 | 6.50e-07 | 1415 | 148 | 21 | 28515276 |
| Pubmed | 6.68e-07 | 39 | 148 | 5 | 38690566 | ||
| Pubmed | IKKα and alternative NF-κB regulate PGC-1β to promote oxidative muscle metabolism. | 7.18e-07 | 17 | 148 | 4 | 22351927 | |
| Pubmed | Developmental regulation of myosin gene expression in mouse cardiac muscle. | 7.50e-07 | 5 | 148 | 3 | 2277065 | |
| Pubmed | 7.50e-07 | 5 | 148 | 3 | 6879174 | ||
| Pubmed | Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections. | 7.50e-07 | 5 | 148 | 3 | 30737693 | |
| Pubmed | Sox6 is required for normal fiber type differentiation of fetal skeletal muscle in mice. | 7.50e-07 | 5 | 148 | 3 | 17584907 | |
| Pubmed | 7.89e-07 | 234 | 148 | 9 | 36243803 | ||
| Pubmed | GTPBP4 MYH7 WAPL DSP DYNC2H1 SMC1A SPTAN1 ECPAS DHX15 SYNE2 EIF4G1 IRAG2 SMARCC1 EIF3M GOLGB1 | 8.75e-07 | 754 | 148 | 15 | 35906200 | |
| Pubmed | 1.33e-06 | 322 | 148 | 10 | 26514267 | ||
| Pubmed | ARHGAP32 UACA DYNC2H1 PPFIA4 SMC1A CEP290 PARP4 RAB3GAP1 TULP4 MACF1 MBD5 PRDM16 | 1.47e-06 | 493 | 148 | 12 | 15368895 | |
| Pubmed | 1.50e-06 | 6 | 148 | 3 | 28381556 | ||
| Pubmed | 1.50e-06 | 6 | 148 | 3 | 20417199 | ||
| Pubmed | A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre. | 1.50e-06 | 6 | 148 | 3 | 17559643 | |
| Pubmed | BRIP1 DSP SMC1A SPTAN1 ARFGEF1 PSMD1 ECPAS DHX15 PARP4 EIF4G1 SMARCC1 EIF3M | 1.50e-06 | 494 | 148 | 12 | 26831064 | |
| Pubmed | 1.57e-06 | 131 | 148 | 7 | 35356984 | ||
| Pubmed | TPM3 GTPBP4 RANBP1 FLOT2 UACA SMC1A SPTAN1 PSMD1 CIT LUZP1 DHX15 SARS1 TULP4 WDR87 SVIL AFG3L2 EIF4G1 SMARCC1 PARD3 | 1.59e-06 | 1247 | 148 | 19 | 27684187 | |
| Pubmed | 1.75e-06 | 191 | 148 | 8 | 33762435 | ||
| Pubmed | Proteomic analysis of a detergent-resistant membrane skeleton from neutrophil plasma membranes. | 1.78e-06 | 21 | 148 | 4 | 12202484 | |
| Pubmed | RAPGEF6 DSP CCDC85C PSMD1 ECPAS LUZP1 TAF1 OBI1 GOLGB1 PCNT S100PBP | 1.94e-06 | 418 | 148 | 11 | 34709266 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | TPM3 RANBP1 MYH7 DSP SMC1A SPTAN1 CAST PSMD1 IPO4 ECPAS LUZP1 DHX15 SARS1 SVIL EIF4G1 MACF1 EEA1 OBI1 | 2.08e-06 | 1149 | 148 | 18 | 35446349 |
| Pubmed | 2.17e-06 | 22 | 148 | 4 | 37468485 | ||
| Pubmed | ARHGAP32 FLOT2 DSP SMC1A PSMD1 ECPAS ADCY9 DHX15 AFG3L2 EIF4G1 MACF1 PARD3 DEPDC1B GOLGB1 | 2.21e-06 | 708 | 148 | 14 | 39231216 | |
| Pubmed | SETMAR WAPL DSP SMC1A SPTAN1 LRSAM1 CEP290 ZNF521 PSMD1 DZIP1 CIT PTPRA GUCY1B1 UBE3A EIF4G1 MACF1 TAF1 MRFAP1L1 PCNT | 2.46e-06 | 1285 | 148 | 19 | 35914814 | |
| Pubmed | 2.61e-06 | 7 | 148 | 3 | 16632484 | ||
| Pubmed | The brain expressed x-linked gene 1 (Bex1) regulates myoblast fusion. | 2.61e-06 | 7 | 148 | 3 | 26586200 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 2.65e-06 | 202 | 148 | 8 | 33005030 | |
| Pubmed | OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ. | 2.65e-06 | 91 | 148 | 6 | 30472188 | |
| Pubmed | 2.83e-06 | 92 | 148 | 6 | 37343697 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TPM3 GTPBP4 RANBP1 FLOT2 WAPL DSP DYNC2H1 SMC1A SPTAN1 PSMD1 IPO4 ECPAS DHX15 SARS1 EIF4G1 SMARCC1 CDC73 EEA1 TDRD6 EIF3M | 2.87e-06 | 1425 | 148 | 20 | 30948266 |
| Pubmed | 2.89e-06 | 274 | 148 | 9 | 34244482 | ||
| Interaction | ACTN2 interactions | TPM3 MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH7B TSC1 CIT CDC73 | 2.10e-09 | 171 | 137 | 12 | int:ACTN2 |
| Interaction | LATS1 interactions | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 SPTAN1 CEP290 CCDC85C KRT73 KIAA1217 SVIL SMARCC1 KIRREL1 PARD3 PCNT | 8.18e-09 | 440 | 137 | 17 | int:LATS1 |
| Interaction | PRKAG2 interactions | 1.95e-08 | 68 | 137 | 8 | int:PRKAG2 | |
| Interaction | HDAC1 interactions | MYH1 MYH2 MYH4 FLOT2 MYH7 MYH8 RAPGEF6 ARID4A SMC1A SPTAN1 ZNF521 ARFGEF1 CCDC85C PSMD1 ECPAS CIT LUZP1 GLI2 SYNE2 SMARCC1 TAF1 PRDM16 OBI1 GOLGB1 PCNT S100PBP | 2.60e-08 | 1108 | 137 | 26 | int:HDAC1 |
| Interaction | ASAH2 interactions | 3.03e-08 | 6 | 137 | 4 | int:ASAH2 | |
| Interaction | RND3 interactions | TPM3 FLOT2 DSP SPTAN1 CCDC85C PSMD1 PLXNB2 CIT ADCY9 KIAA1217 KIRREL1 PARD3 DEPDC1B | 4.66e-08 | 273 | 137 | 13 | int:RND3 |
| Interaction | RND1 interactions | FLOT2 MYH7 DSP SPTAN1 PSMD1 DZIP1 PLXNB2 ADCY9 AFG3L2 KIRREL1 PARD3 DEPDC1B | 1.21e-07 | 246 | 137 | 12 | int:RND1 |
| Interaction | GJA1 interactions | DENND5B ARHGAP32 FLOT2 MYH6 MYH7 UACA SPTAN1 ARFGEF1 DZIP1 ADCY9 KIAA1217 SYNE2 KIRREL1 MACF1 PARD3 DEPDC1B GOLGB1 | 4.66e-07 | 583 | 137 | 17 | int:GJA1 |
| Interaction | PHF21A interactions | TPM3 RAPGEF6 DSP CCDC85C PSMD1 ECPAS TUFT1 LUZP1 TAF1 OBI1 GOLGB1 PCNT S100PBP | 6.43e-07 | 343 | 137 | 13 | int:PHF21A |
| Interaction | H3C1 interactions | GTPBP4 BRIP1 WAPL DSP DYNC2H1 SMC1A SPTAN1 CEP290 CAST IPO4 SARS1 UBN1 WDR87 EIF4G1 MYH15 TAF1 CDC73 MBD5 USP48 PRDM16 DNAH8 | 7.62e-07 | 901 | 137 | 21 | int:H3C1 |
| Interaction | FLOT1 interactions | RANBP1 ARHGAP32 FLOT2 SPTAN1 CCDC85C DZIP1 ECPAS CIT KIAA1217 SVIL AFG3L2 KIRREL1 MACF1 MYH15 PARD3 | 8.63e-07 | 475 | 137 | 15 | int:FLOT1 |
| Interaction | POTED interactions | 1.22e-06 | 4 | 137 | 3 | int:POTED | |
| Interaction | TMEM260 interactions | 1.39e-06 | 13 | 137 | 4 | int:TMEM260 | |
| Interaction | RCOR1 interactions | TPM3 RAPGEF6 ARID4A DSP SPTAN1 CCDC85C PSMD1 ECPAS TUFT1 LUZP1 SMARCC1 TAF1 PRDM16 OBI1 S100PBP | 1.41e-06 | 494 | 137 | 15 | int:RCOR1 |
| Interaction | YWHAH interactions | ARHGAP32 FLOT2 RAPGEF6 UACA DSP SPTAN1 CEP290 CCDC85C TSC1 DZIP1 LUZP1 PRICKLE3 UBE3A KIAA1217 SVIL SYNE2 EIF4G1 ANKRD11 MACF1 PARD3 USP48 DEPDC1B PCNT | 1.43e-06 | 1102 | 137 | 23 | int:YWHAH |
| Interaction | NDC80 interactions | UACA SMC1A CEP290 CCDC85C CAGE1 LUZP1 NDC80 KIAA1217 SYNE2 SKA1 CCDC136 PCNT | 1.52e-06 | 312 | 137 | 12 | int:NDC80 |
| Interaction | PCM1 interactions | MIS18BP1 DSP CEP290 CCDC85C TSC1 ECPAS LUZP1 KRT73 NDC80 GLI2 KIAA1217 EEA1 SKA1 PCNT | 1.59e-06 | 434 | 137 | 14 | int:PCM1 |
| Interaction | RHOD interactions | ARHGAP32 FLOT2 SPTAN1 CCDC85C PSMD1 SLC7A6 PLXNB2 ADCY9 RAB3GAP1 SYNE2 AFG3L2 KIRREL1 MACF1 PARD3 DEPDC1B GOLGB1 | 1.79e-06 | 572 | 137 | 16 | int:RHOD |
| Interaction | DNAJC5 interactions | FLOT2 UACA PPFIA4 SPTAN1 DZIP1 ADCY9 AFG3L2 KIRREL1 MACF1 PARD3 USP48 DEPDC1B GOLGB1 | 1.90e-06 | 378 | 137 | 13 | int:DNAJC5 |
| Interaction | TTC3 interactions | 2.11e-06 | 124 | 137 | 8 | int:TTC3 | |
| Interaction | PSMC2 interactions | TPM3 SMC1A PSMD1 IPO4 ECPAS NDC80 UBE3A GLI2 EIF4G1 NFX1 CDC73 USP48 PRDM16 | 2.91e-06 | 393 | 137 | 13 | int:PSMC2 |
| Interaction | AFDN interactions | ARHGAP32 FLOT2 CCDC85C PSMD1 ADCY9 PRICKLE3 KIAA1217 KIRREL1 MACF1 PARD3 DEPDC1B GOLGB1 | 2.98e-06 | 333 | 137 | 12 | int:AFDN |
| Interaction | PSMD14 interactions | DENND5B BRIP1 DSP FSIP1 ASAP3 PSMD1 ECPAS DHX15 PTPRA UBE3A CARD9 SYNE2 EIF4G1 NFX1 PCNT | 3.11e-06 | 527 | 137 | 15 | int:PSMD14 |
| Interaction | RSPH6A interactions | 3.20e-06 | 34 | 137 | 5 | int:RSPH6A | |
| Interaction | CIT interactions | TPM3 GTPBP4 RANBP1 ARHGAP32 FLOT2 DSP DYNC2H1 SMC1A SPTAN1 ESRP1 RRP8 CFAP43 ECPAS TEKT5 CIT LUZP1 DHX15 SVIL SYNE2 EIF4G1 SMARCC1 MACF1 CDC73 TOP1MT PARD3 EIF3M | 4.50e-06 | 1450 | 137 | 26 | int:CIT |
| Interaction | ABTB2 interactions | 5.81e-06 | 101 | 137 | 7 | int:ABTB2 | |
| Interaction | RHOA interactions | GTPBP4 ARHGAP32 FLOT2 SPTAN1 CCDC85C PSMD1 IPO4 SLC7A6 PLXNB2 CIT ADCY9 KLHL20 RAB3GAP1 SYNE2 AFG3L2 KIRREL1 MACF1 UQCRH PARD3 MBD5 USP48 DEPDC1B GOLGB1 | 5.87e-06 | 1199 | 137 | 23 | int:RHOA |
| Interaction | RAB5A interactions | GTPBP4 FLOT2 SPTAN1 FAM114A2 TSC1 CIT ADCY9 RAB3GAP1 SYNE2 KIRREL1 MACF1 CDC73 EEA1 UQCRH DEPDC1B EIF3M GOLGB1 | 6.22e-06 | 706 | 137 | 17 | int:RAB5A |
| Interaction | MECOM interactions | GTPBP4 MYH1 MYH2 MYH4 MYH7 MYH8 SMC1A CAGE1 DZIP1 DHX15 ANKRD11 UQCRH | 6.24e-06 | 358 | 137 | 12 | int:MECOM |
| Interaction | PARD3 interactions | ARHGAP32 FLOT2 RAPGEF6 UACA CCDC85C DZIP1 CIT KIAA1217 KIRREL1 PARD3 DEPDC1B | 6.24e-06 | 298 | 137 | 11 | int:PARD3 |
| Interaction | DISC1 interactions | TPM3 FLOT2 MYH7 PPFIA4 SPTAN1 CEP290 CIT LUZP1 CARD9 SVIL MACF1 CCDC136 PCNT | 7.53e-06 | 429 | 137 | 13 | int:DISC1 |
| Interaction | SLC39A3 interactions | 8.11e-06 | 70 | 137 | 6 | int:SLC39A3 | |
| Interaction | RAB35 interactions | DENND5B ARHGAP32 FLOT2 UACA SPTAN1 DZIP1 PLXNB2 ADCY9 UBE3A SYNE2 KIRREL1 MACF1 PARD3 DEPDC1B GOLGB1 | 8.51e-06 | 573 | 137 | 15 | int:RAB35 |
| Interaction | KIF20A interactions | TPM3 CAPN12 GTPBP4 FLOT2 ZFAT MIS18BP1 UACA DSP DYNC2H1 SPTAN1 ESRP1 PABPC5 CIT LUZP1 DHX15 SVIL SYNE2 IRAG2 MACF1 TOP1MT PARD3 | 8.64e-06 | 1052 | 137 | 21 | int:KIF20A |
| Interaction | YWHAG interactions | TPM3 GTPBP4 ARHGAP32 RAPGEF6 UACA DSP SPTAN1 CCDC85C PSMD1 TSC1 DZIP1 LUZP1 DHX15 PRICKLE3 UBE3A SVIL SYNE2 EIF4G1 ANKRD11 MACF1 PARD3 USP48 DEPDC1B | 1.13e-05 | 1248 | 137 | 23 | int:YWHAG |
| Interaction | DIRAS3 interactions | FLOT2 SPTAN1 PSMD1 ECPAS ADCY9 AFG3L2 KIRREL1 MACF1 PARD3 DEPDC1B | 1.25e-05 | 262 | 137 | 10 | int:DIRAS3 |
| Interaction | CDK3 interactions | 1.29e-05 | 114 | 137 | 7 | int:CDK3 | |
| Interaction | FBXO32 interactions | GTPBP4 MYH1 MYH3 MYH4 MYH6 MYH8 DSP RRP8 UBE3A USP48 PRDM16 EIF3M | 1.33e-05 | 386 | 137 | 12 | int:FBXO32 |
| Interaction | TMOD1 interactions | 1.46e-05 | 161 | 137 | 8 | int:TMOD1 | |
| Interaction | NINL interactions | RANBP1 MIS18BP1 DSP DYNC2H1 LRSAM1 CEP290 CCDC85C TSC1 LUZP1 KIAA1217 SVIL UQCRH PCNT | 1.51e-05 | 458 | 137 | 13 | int:NINL |
| Interaction | ZYX interactions | ARHGAP32 UBAP1 CIT TUFT1 LUZP1 DHX15 KIAA1217 SVIL MACF1 SKA1 PCNT | 1.58e-05 | 329 | 137 | 11 | int:ZYX |
| Interaction | AURKB interactions | TPM3 GTPBP4 DSP SMC1A PABPC5 CIT DHX15 NDC80 SMARCC1 MACF1 TAF1 CDC73 MBD5 SKA1 USP48 OBI1 EIF3M | 1.65e-05 | 761 | 137 | 17 | int:AURKB |
| Interaction | CNTROB interactions | 1.82e-05 | 166 | 137 | 8 | int:CNTROB | |
| Interaction | SIX1 interactions | 2.02e-05 | 49 | 137 | 5 | int:SIX1 | |
| Interaction | KDM1A interactions | TPM3 RAPGEF6 DSP CCDC85C PSMD1 TSC1 CAGE1 ECPAS CIT TUFT1 LUZP1 DHX15 KIAA1217 SMARCC1 TAF1 OBI1 GOLGB1 PCNT S100PBP | 2.07e-05 | 941 | 137 | 19 | int:KDM1A |
| Interaction | GOLGA4 interactions | 2.47e-05 | 226 | 137 | 9 | int:GOLGA4 | |
| Interaction | BCAP31 interactions | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH7B CEP290 PSMD1 ADCY9 RAB3GAP1 SYNE2 MYH15 | 2.55e-05 | 554 | 137 | 14 | int:BCAP31 |
| Interaction | CTNNA1 interactions | RANBP1 ARHGAP32 SPTAN1 CCDC85C ECT2L CIT KIAA1217 AFG3L2 MACF1 PARD3 OBI1 | 2.58e-05 | 347 | 137 | 11 | int:CTNNA1 |
| Interaction | HSPB1 interactions | TPM3 ZFAT ERCC5 CAST PSMD1 ECPAS CIT ADCY9 LUZP1 DHX15 PTPRA SARS1 KIAA1217 EIF4G1 CDC73 EIF3M | 2.58e-05 | 708 | 137 | 16 | int:HSPB1 |
| Interaction | SYCE1 interactions | 2.61e-05 | 127 | 137 | 7 | int:SYCE1 | |
| Interaction | TNNI1 interactions | 3.27e-05 | 54 | 137 | 5 | int:TNNI1 | |
| Interaction | ECT2 interactions | TPM3 GTPBP4 FLOT2 DSP SPTAN1 PSMD1 RRP8 PABPC5 CIT KLHL20 LUZP1 DHX15 PARP4 SVIL MACF1 TOP1MT PARD3 EIF3M | 3.27e-05 | 887 | 137 | 18 | int:ECT2 |
| Interaction | STK3 interactions | 3.38e-05 | 181 | 137 | 8 | int:STK3 | |
| Interaction | NAA40 interactions | TPM3 GTPBP4 RANBP1 FLOT2 RAPGEF6 WAPL DSP CAST CCDC85C FAM114A2 TSC1 CIT ALDH1A2 KIAA1217 AFG3L2 MACF1 DEPDC1B GOLGB1 PCNT | 3.52e-05 | 978 | 137 | 19 | int:NAA40 |
| Interaction | OCLN interactions | ARHGAP32 FLOT2 RAPGEF6 UACA SPTAN1 CCDC85C DZIP1 ADCY9 KIRREL1 MACF1 PARD3 DEPDC1B GOLGB1 | 3.76e-05 | 500 | 137 | 13 | int:OCLN |
| Interaction | MYH6 interactions | 4.41e-05 | 94 | 137 | 6 | int:MYH6 | |
| Interaction | RND2 interactions | FLOT2 SPTAN1 PSMD1 PLXNB2 ADCY9 RAB3GAP1 SYNE2 AFG3L2 KIRREL1 PARD3 DEPDC1B GOLGB1 | 4.79e-05 | 440 | 137 | 12 | int:RND2 |
| Interaction | RHOH interactions | TPM3 FLOT2 UACA SPTAN1 PSMD1 TSC1 PLXNB2 ADCY9 AFG3L2 KIRREL1 PARD3 DEPDC1B GOLGB1 | 4.79e-05 | 512 | 137 | 13 | int:RHOH |
| Interaction | ANKRD24 interactions | 4.87e-05 | 11 | 137 | 3 | int:ANKRD24 | |
| Interaction | SPICE1 interactions | 4.96e-05 | 191 | 137 | 8 | int:SPICE1 | |
| Interaction | CTNNB1 interactions | TPM3 RANBP1 ARHGAP32 UACA SPTAN1 ARFGEF1 CCDC85C PSMD1 TSC1 CIT PTPRA UBE3A KIAA1217 SVIL SYNE2 CDC73 PARD3 USP48 DEPDC1B | 5.35e-05 | 1009 | 137 | 19 | int:CTNNB1 |
| Interaction | C11orf52 interactions | ARHGAP32 FLOT2 UACA SPTAN1 ADCY9 AFG3L2 KIRREL1 MACF1 PARD3 DEPDC1B | 5.40e-05 | 311 | 137 | 10 | int:C11orf52 |
| Interaction | MSX2 interactions | 5.74e-05 | 195 | 137 | 8 | int:MSX2 | |
| Interaction | ADCY4 interactions | 6.46e-05 | 12 | 137 | 3 | int:ADCY4 | |
| Interaction | GJD3 interactions | FLOT2 SPTAN1 ARFGEF1 PSMD1 FAM114A2 ADCY9 RAB3GAP1 SYNE2 AFG3L2 KIRREL1 DEPDC1B GOLGB1 | 6.47e-05 | 454 | 137 | 12 | int:GJD3 |
| Interaction | MYH7 interactions | 6.60e-05 | 101 | 137 | 6 | int:MYH7 | |
| Interaction | MKRN2 interactions | DYNC2H1 CEP290 PABPC5 PTPRA GLI2 SYNE2 NFX1 MACF1 TAF1 PARD3 PCNT | 6.62e-05 | 385 | 137 | 11 | int:MKRN2 |
| Interaction | HSF1 interactions | TPM3 DENND5B GTPBP4 DSP SMC1A LRSAM1 PSMD1 DHX15 UBE3A SYNE2 EIF4G1 TAF1 EIF3M GOLGB1 | 7.10e-05 | 609 | 137 | 14 | int:HSF1 |
| Interaction | TPM1 interactions | 8.02e-05 | 263 | 137 | 9 | int:TPM1 | |
| Interaction | YWHAZ interactions | ARHGAP32 RAPGEF6 UACA SMC1A SPTAN1 CCDC85C TSC1 DZIP1 LUZP1 PTPRA PRICKLE3 UBE3A SVIL SYNE2 NFX1 IRAG2 MACF1 CDC73 PARD3 USP48 DEPDC1B PCNT | 8.03e-05 | 1319 | 137 | 22 | int:YWHAZ |
| Interaction | TSPAN33 interactions | 8.03e-05 | 65 | 137 | 5 | int:TSPAN33 | |
| Interaction | LRRC31 interactions | 8.14e-05 | 205 | 137 | 8 | int:LRRC31 | |
| Interaction | POTEC interactions | 8.36e-05 | 13 | 137 | 3 | int:POTEC | |
| Interaction | RAC3 interactions | ARHGAP32 FLOT2 UACA SPTAN1 PLXNB2 ADCY9 KIAA1217 AFG3L2 ANKRD11 KIRREL1 MACF1 PARD3 DEPDC1B GOLGB1 | 8.44e-05 | 619 | 137 | 14 | int:RAC3 |
| Interaction | FGD5 interactions | 8.71e-05 | 207 | 137 | 8 | int:FGD5 | |
| Interaction | PPP1CB interactions | TPM3 UACA SPTAN1 CCDC85C CIT LUZP1 HOXA2 DHX15 SVIL EIF4G1 USP48 PRDM16 | 8.80e-05 | 469 | 137 | 12 | int:PPP1CB |
| Interaction | KIAA0753 interactions | 1.00e-04 | 157 | 137 | 7 | int:KIAA0753 | |
| Interaction | BRCA1 interactions | TPM3 BRIP1 WAPL ERCC5 DSP SMC1A SPTAN1 ARFGEF1 PSMD1 ECPAS CIT LUZP1 HOXA2 DHX15 PARP4 UBE3A EIF4G1 SMARCC1 CDC73 USP48 EIF3M | 1.06e-04 | 1249 | 137 | 21 | int:BRCA1 |
| Interaction | STK4 interactions | 1.09e-04 | 159 | 137 | 7 | int:STK4 | |
| Interaction | EPHA2 interactions | ARHGAP32 FLOT2 RAPGEF6 UACA DZIP1 PLXNB2 F3 ADCY9 KIAA1217 AFG3L2 KIRREL1 MACF1 PARD3 DEPDC1B GOLGB1 | 1.15e-04 | 719 | 137 | 15 | int:EPHA2 |
| Interaction | ACTN1 interactions | 1.16e-04 | 341 | 137 | 10 | int:ACTN1 | |
| Interaction | LYN interactions | ARHGAP32 FLOT2 UACA DSP SPTAN1 DZIP1 PLXNB2 ADCY9 KIAA1217 SVIL AFG3L2 KIRREL1 MACF1 PARD3 DEPDC1B | 1.16e-04 | 720 | 137 | 15 | int:LYN |
| Interaction | ZSCAN5A interactions | 1.26e-04 | 38 | 137 | 4 | int:ZSCAN5A | |
| Interaction | RAB2A interactions | RANBP1 FLOT2 CEP290 ARFGEF1 FAM114A2 TSC1 SLC7A6 PLXNB2 ADCY9 KIRREL1 CDC73 DEPDC1B GOLGB1 | 1.34e-04 | 567 | 137 | 13 | int:RAB2A |
| Interaction | USP37 interactions | 1.36e-04 | 115 | 137 | 6 | int:USP37 | |
| Interaction | KRT19 interactions | 1.36e-04 | 282 | 137 | 9 | int:KRT19 | |
| Interaction | SMC5 interactions | MYH1 MYH4 BRIP1 WAPL ARID4A DSP SMC1A CAST RRP8 LUZP1 DHX15 UBN1 EIF4G1 ANKRD11 SMARCC1 TAF1 CDC73 UQCRH | 1.51e-04 | 1000 | 137 | 18 | int:SMC5 |
| Interaction | CFTR interactions | TPM3 MYH1 MYH2 MYH3 MYH4 RANBP1 FLOT2 MYH6 MYH7 MYH8 DSP MYH7B SPTAN1 CAST PSMD1 PABPC5 IPO4 FGL2 UBE3A SVIL MACF1 EEA1 EIF3M | 1.57e-04 | 1480 | 137 | 23 | int:CFTR |
| Interaction | MYCBP2 interactions | UACA SPTAN1 GUCY1B1 UBE3A SVIL SYNE2 SMARCC1 MACF1 EEA1 SKA1 | 1.61e-04 | 355 | 137 | 10 | int:MYCBP2 |
| Interaction | RNF43 interactions | ARHGAP32 MIS18BP1 CCDC85C UBAP1 KIAA1217 SVIL NFX1 KIRREL1 MACF1 PARD3 GOLGB1 | 1.65e-04 | 427 | 137 | 11 | int:RNF43 |
| Interaction | HERC2 interactions | CEP290 PSMD1 DHX15 NDC80 UBE3A SYNE2 EIF4G1 MACF1 TAF1 EIF3M CCDC136 MRFAP1L1 | 1.69e-04 | 503 | 137 | 12 | int:HERC2 |
| Interaction | CCHCR1 interactions | 1.75e-04 | 229 | 137 | 8 | int:CCHCR1 | |
| Interaction | HSPB8 interactions | 1.77e-04 | 172 | 137 | 7 | int:HSPB8 | |
| Interaction | RHOB interactions | GTPBP4 ARHGAP32 FLOT2 RAPGEF6 UACA SPTAN1 PSMD1 SLC7A6 PLXNB2 CIT ADCY9 AFG3L2 KIRREL1 MACF1 PARD3 DEPDC1B | 1.91e-04 | 840 | 137 | 16 | int:RHOB |
| Interaction | MYH9 interactions | TPM3 UACA SPTAN1 ARFGEF1 PSMD1 CIT LUZP1 UBE3A SVIL EIF4G1 NFX1 SMARCC1 MACF1 CDC73 USP48 | 1.93e-04 | 754 | 137 | 15 | int:MYH9 |
| Interaction | RHOF interactions | ARHGAP32 FLOT2 UACA SPTAN1 ECPAS SLC7A6 PLXNB2 ADCY9 AFG3L2 KIRREL1 MACF1 PARD3 DEPDC1B GOLGB1 | 2.02e-04 | 673 | 137 | 14 | int:RHOF |
| Interaction | AURKC interactions | 2.05e-04 | 43 | 137 | 4 | int:AURKC | |
| Interaction | RAB9A interactions | GTPBP4 FLOT2 SMC1A ARFGEF1 TSC1 ECPAS PLXNB2 ADCY9 RAB3GAP1 SYNE2 EEA1 DEPDC1B GOLGB1 | 2.14e-04 | 595 | 137 | 13 | int:RAB9A |
| Interaction | CXADR interactions | ARHGAP32 FLOT2 DZIP1 ADCY9 SYNE2 KIRREL1 MACF1 PARD3 DEPDC1B GOLGB1 | 2.19e-04 | 369 | 137 | 10 | int:CXADR |
| Interaction | EBAG9 interactions | FLOT2 SPTAN1 ARFGEF1 FAM114A2 RAB3GAP1 KIRREL1 PARD3 DEPDC1B GOLGB1 | 2.33e-04 | 303 | 137 | 9 | int:EBAG9 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | SPDYE17 SPDYE10 SPDYE9 SPDYE12 FGL2 SPDYE11 SPDYE13 SPDYE15 SPDYE8 SPDYE14 | 2.46e-08 | 271 | 150 | 10 | chr7q11 |
| Cytoband | 7q11.23 | 1.76e-05 | 97 | 150 | 5 | 7q11.23 | |
| Cytoband | 17p13.1 | 4.53e-05 | 118 | 150 | 5 | 17p13.1 | |
| Cytoband | 14q12 | 7.92e-04 | 55 | 150 | 3 | 14q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 1.01e-03 | 346 | 150 | 6 | chr17p13 | |
| GeneFamily | Myosin heavy chains | 1.63e-17 | 15 | 100 | 9 | 1098 | |
| GeneFamily | Speedy/RINGO cell cycle regulator family | 3.48e-05 | 12 | 100 | 3 | 756 | |
| GeneFamily | EF-hand domain containing|Plakins | 8.30e-04 | 8 | 100 | 2 | 939 | |
| Coexpression | HALLMARK_MYOGENESIS | TPM3 MYH1 MYH2 MYH3 MYH4 MYH7 MYH8 PPFIA4 SPTAN1 PLXNB2 ADCY9 SVIL | 1.20e-09 | 200 | 144 | 12 | M5909 |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 6.77e-08 | 20 | 144 | 5 | M1123 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 8.85e-08 | 21 | 144 | 5 | MM1102 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 2.77e-06 | 212 | 144 | 9 | M39221 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | STARD13 WAPL ARID4A ARFGEF1 F3 ADCY9 KLHL20 DNAJC2 DHX15 RAB3GAP1 PTPRA NDC80 UBE3A SYNE2 MACF1 PARD3 PCNT | 5.00e-06 | 856 | 144 | 17 | M4500 |
| Coexpression | DAIRKEE_CANCER_PRONE_RESPONSE_BPA | 8.95e-06 | 51 | 144 | 5 | M8655 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_DN | 1.39e-05 | 197 | 144 | 8 | M9916 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 1.49e-05 | 199 | 144 | 8 | M5893 | |
| Coexpression | GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_DN | 1.55e-05 | 200 | 144 | 8 | M5169 | |
| Coexpression | GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_WITH_IL2_TREATMENT_UP | 1.55e-05 | 200 | 144 | 8 | M9281 | |
| Coexpression | GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_UP | 1.55e-05 | 200 | 144 | 8 | M7449 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | RAPGEF6 MIS18BP1 ERCC5 CEP290 CAST ARFGEF1 DZIP1 NDC80 UBE3A SYNE2 EEA1 USP48 OBI1 GOLGB1 | 1.63e-05 | 656 | 144 | 14 | M18979 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | RANBP1 FLOT2 WAPL WBP1L CEP290 UBAP1 TSC1 ECPAS SLC7A6 UBE3A SYNE2 AFG3L2 NFX1 SMARCC1 MACF1 EEA1 EIF3M MRFAP1L1 S100PBP | 3.88e-05 | 1215 | 144 | 19 | M41122 |
| Coexpression | DESCARTES_MAIN_FETAL_SKELETAL_MUSCLE_CELLS | 1.02e-04 | 194 | 144 | 7 | M40093 | |
| Coexpression | LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2 | 1.14e-04 | 86 | 144 | 5 | M39248 | |
| Coexpression | GSE27786_CD8_TCELL_VS_MONO_MAC_UP | 1.20e-04 | 199 | 144 | 7 | M4848 | |
| Coexpression | GSE22886_CD8_TCELL_VS_BCELL_NAIVE_UP | 1.20e-04 | 199 | 144 | 7 | M4427 | |
| Coexpression | GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_UP | 1.23e-04 | 200 | 144 | 7 | M5041 | |
| Coexpression | EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION | 1.41e-04 | 48 | 144 | 4 | M16123 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | TPM3 WAPL MIS18BP1 UACA ARID4A SMC1A CEP290 ECPAS CIT LUZP1 DNAJC2 ANKRD11 SMARCC1 PARD3 SKA1 | 5.09e-07 | 469 | 140 | 15 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | TPM3 GTPBP4 RANBP1 WAPL SPTAN1 CEP290 ECPAS CIT LUZP1 DNAJC2 NDC80 ANKRD11 SMARCC1 SKA1 PCNT | 2.44e-06 | 532 | 140 | 15 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 5.30e-06 | 192 | 140 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | PUS3 SMC1A CIT ALDH1A2 UBE3A KIAA1217 SYNE2 EIF4G1 ANKRD11 SMARCC1 | 1.78e-05 | 281 | 140 | 10 | gudmap_developingGonad_e18.5_epididymis_1000_k3 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | PUS3 SMC1A CIT ALDH1A2 UBE3A KIAA1217 SYNE2 EIF4G1 ANKRD11 SMARCC1 | 1.95e-05 | 284 | 140 | 10 | gudmap_developingGonad_e16.5_epididymis_1000_k2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | MIS18BP1 ARID4A SMC1A CEP290 ARFGEF1 ECPAS CIT LUZP1 SERPINB8 MACF1 SKA1 GOLGB1 | 3.01e-05 | 432 | 140 | 12 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | GTPBP4 RANBP1 ARHGAP32 ARID4A DYNC2H1 SMC1A CEP290 UBAP1 PLXNB2 CIT LUZP1 DNAJC2 GLI2 SYNE2 EEA1 SKA1 USP48 | 3.45e-05 | 831 | 140 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 4.17e-05 | 192 | 140 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | ARHGAP32 MIS18BP1 ARID4A SMC1A CEP290 UBAP1 TSC1 PLXNB2 CIT LUZP1 GLI2 SYNE2 MACF1 EEA1 MBD5 USP48 | 5.78e-05 | 780 | 140 | 16 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 6.18e-05 | 203 | 140 | 8 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 6.39e-05 | 204 | 140 | 8 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | TPM3 RANBP1 WAPL MIS18BP1 PUS3 ERCC5 ARID4A SMC1A CEP290 CIT LUZP1 DNAJC2 NDC80 GLI2 SYNE2 SMARCC1 MACF1 MBD5 SKA1 PRDM16 OBI1 | 7.69e-05 | 1257 | 140 | 21 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | DENND5B PUS3 CIT ALDH1A2 UBE3A KIAA1217 SYNE2 EIF4G1 ANKRD11 | 9.49e-05 | 277 | 140 | 9 | gudmap_developingGonad_e12.5_ovary_k3_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.38e-04 | 291 | 140 | 9 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | DENND5B MIS18BP1 ARID4A SMC1A CEP290 ARFGEF1 ECPAS CIT LUZP1 ALDH1A2 SERPINB8 SYNE2 MACF1 TAF1 SKA1 PRDM16 GOLGB1 | 2.82e-04 | 989 | 140 | 17 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | STARD13 DENND5B MIS18BP1 ARID4A ZNF521 RRP8 DZIP1 HOXA2 ALDH1A2 OLFML1 GUCY1B1 KIAA1217 KIRREL1 SKA1 DEPDC1B | 3.39e-04 | 819 | 140 | 15 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-07 | 186 | 146 | 8 | 9feef5936985e936b3d88f9d1bb012abb6468570 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-07 | 186 | 146 | 8 | 89f5b06bc56674af304912d481ac697c7c870904 | |
| ToppCell | Bronchial_Biopsy|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.06e-07 | 198 | 146 | 8 | f5b7013045b61fc56894f80092f799770dde1c8f | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 3.18e-07 | 199 | 146 | 8 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.30e-07 | 200 | 146 | 8 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.30e-07 | 200 | 146 | 8 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 174 | 146 | 7 | 9d5dcd46cf346c381dea68ada6665f7fb68114a3 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 174 | 146 | 7 | 53cec5c666c45278a71c21dd9c62a052a97e0fdf | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.75e-06 | 186 | 146 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-06 | 191 | 146 | 7 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-06 | 191 | 146 | 7 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-06 | 192 | 146 | 7 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.64e-06 | 194 | 146 | 7 | c197e4acbff42a9f0410b6801c2bfcf6160aefc1 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 3.76e-06 | 195 | 146 | 7 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 3.76e-06 | 195 | 146 | 7 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 3.76e-06 | 195 | 146 | 7 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 3.89e-06 | 196 | 146 | 7 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 3.89e-06 | 196 | 146 | 7 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.02e-06 | 197 | 146 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.30e-06 | 199 | 146 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 4.30e-06 | 199 | 146 | 7 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 4.30e-06 | 199 | 146 | 7 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Myh4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.31e-06 | 129 | 146 | 6 | f83187c0bb06528127b8d2d56674ab1946846951 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.44e-06 | 200 | 146 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 4.44e-06 | 200 | 146 | 7 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 4.44e-06 | 200 | 146 | 7 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 4.44e-06 | 200 | 146 | 7 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Syt15_(Medial_habenula)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.50e-06 | 77 | 146 | 5 | 7f624e9262bd0dc2ac4176f43c91a4bc0f521fe5 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.15e-05 | 153 | 146 | 6 | d7635f3d4831c02a94f53afc674847d5b51453be | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.15e-05 | 153 | 146 | 6 | 54a941950bbb848077c7bd5726da9e4b3244bd38 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.15e-05 | 153 | 146 | 6 | 69a8550418ba0fc908a84b3b85761abb6e8ca4c0 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.15e-05 | 153 | 146 | 6 | e50d20f9e553b8c3e10e187770d8abe1a43d109e | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-05 | 163 | 146 | 6 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.95e-05 | 168 | 146 | 6 | c70bf73bb800e4722cedc35bbc17ea3113d1012d | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.09e-05 | 170 | 146 | 6 | 985c2d5962100fab0d95bee39f382ccbe799331e | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.38e-05 | 174 | 146 | 6 | 3503c7dec498597f76a86dbd5e4bb2311e743bde | |
| ToppCell | (01)_Cycling_Basal_(homeostasis)|World / shred by cell type and Timepoint | 2.62e-05 | 177 | 146 | 6 | 05c57578142a6662f18b294d5cc11e6efd6b0f8e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-05 | 178 | 146 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.79e-05 | 179 | 146 | 6 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.88e-05 | 180 | 146 | 6 | 44988c34861df359a68376500c42a64fbcc4b431 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.88e-05 | 180 | 146 | 6 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.97e-05 | 181 | 146 | 6 | e482fd116c00ff4d8db7be3c06b1bd1ffa2d479d | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.97e-05 | 181 | 146 | 6 | 2be3d44619adb25d339e7a27b500a56e07e8de01 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 182 | 146 | 6 | bc6a120dedc813c58baac1428c39851a07b71ba7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-05 | 182 | 146 | 6 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.35e-05 | 185 | 146 | 6 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 3.35e-05 | 185 | 146 | 6 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMH+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.35e-05 | 185 | 146 | 6 | 097d628f92e13250c15b550f2fd1f4225fc07558 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.46e-05 | 186 | 146 | 6 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.67e-05 | 188 | 146 | 6 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 189 | 146 | 6 | bfa3ed1360991a3e32fad133017c413f8adc1eba | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 189 | 146 | 6 | 96f10c63656e446b4bb712f012e91ae986f8c2d0 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.78e-05 | 189 | 146 | 6 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.78e-05 | 189 | 146 | 6 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.89e-05 | 190 | 146 | 6 | b99271d139c8d01e20feb95d99f79c9b2756b4cb | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.01e-05 | 191 | 146 | 6 | 15dbc5a03bfab8931c0fd385b0f25874736ae874 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.01e-05 | 191 | 146 | 6 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.01e-05 | 191 | 146 | 6 | 45c15f5ce4a207ac944bed65d45f06c1657d1a6d | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.01e-05 | 191 | 146 | 6 | b978afe76754cc56e1672abca27be289bb56375b | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-05 | 191 | 146 | 6 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.13e-05 | 192 | 146 | 6 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 4.13e-05 | 192 | 146 | 6 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.13e-05 | 192 | 146 | 6 | 39804d9ddc67c1b41887752df2503389eae44a1a | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-05 | 192 | 146 | 6 | 96f23d6e8604d1cb24910d3118d8171b57c93e14 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.37e-05 | 194 | 146 | 6 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.37e-05 | 194 | 146 | 6 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | CTRL-Epithelial-Epithelial_cell|CTRL / Disease state, Lineage and Cell class | 4.37e-05 | 194 | 146 | 6 | 2bc4deaf2a01a39809fc323962fce4286835209c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.37e-05 | 194 | 146 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | CTRL-Epithelial|CTRL / Disease state, Lineage and Cell class | 4.37e-05 | 194 | 146 | 6 | 49dcb31427f370692308f939e23992925708abb7 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.50e-05 | 195 | 146 | 6 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | Healthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class | 4.50e-05 | 195 | 146 | 6 | 957458fdc39723f4a31bd7fd3ce32891aa3fd462 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.50e-05 | 195 | 146 | 6 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-05 | 195 | 146 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.63e-05 | 196 | 146 | 6 | cb61757646653f89faba503cb5d99e5dd5197b4c | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 4.63e-05 | 196 | 146 | 6 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.63e-05 | 196 | 146 | 6 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 4.63e-05 | 196 | 146 | 6 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.63e-05 | 196 | 146 | 6 | 44e2df1b61e3819eae7e482bef0a733afe852d67 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.76e-05 | 197 | 146 | 6 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.76e-05 | 197 | 146 | 6 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_dorsal_progenitors|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 4.90e-05 | 198 | 146 | 6 | 5f0964c3aa7e1dc52cbb46e754078920b65bcb88 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 4.90e-05 | 198 | 146 | 6 | 629d674a9c9108c1acb3f7af57bbdbf34bb0528e | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 4.90e-05 | 198 | 146 | 6 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.03e-05 | 199 | 146 | 6 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.03e-05 | 199 | 146 | 6 | 305a9ade5bbe8e981e7c641c9a5e0c9f8ef60470 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 5.03e-05 | 199 | 146 | 6 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_dorsal_progenitors|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 5.03e-05 | 199 | 146 | 6 | ca17e8c0f5bc2c41ce28351a7418d934404e563b | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.03e-05 | 199 | 146 | 6 | 101f78fe6dd1bf9e2e4dd5ad8a970312b3540927 | |
| ToppCell | normal_Lung-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 5.03e-05 | 199 | 146 | 6 | 4142d5b1b20212508f95841fdac4efb7655616cb | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.03e-05 | 199 | 146 | 6 | e0fcec796afe75e42467ca86355b9fc5aa9ae0a1 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 5.03e-05 | 199 | 146 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.03e-05 | 199 | 146 | 6 | fba48342066aab41a8bcb20db40a6df0158e1cbe | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.03e-05 | 199 | 146 | 6 | 1d5a3366474c17e3df0ba5cf11b586655529e9bd | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 5.03e-05 | 199 | 146 | 6 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | critical-Lymphoid-NKT-proliferating|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.03e-05 | 199 | 146 | 6 | 9284956d852e434a91be892e88e06a7c71f8c583 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.03e-05 | 199 | 146 | 6 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.03e-05 | 199 | 146 | 6 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | Transverse-B_cell-B_cell_cycling|B_cell / Region, Cell class and subclass | 5.03e-05 | 199 | 146 | 6 | 170ae68963d31f3b821b6f0e8f0c039bea0bc981 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.13e-05 | 62 | 146 | 4 | a20620a8869721ea62984c2022ee1b484b455824 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.13e-05 | 62 | 146 | 4 | ee694c06bcd924b4ddf744178ba3a99e04eed51b | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.65e-05 | 50 | 86 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Drug | purealin | 9.08e-11 | 58 | 142 | 9 | CID006419303 | |
| Drug | fast white | 1.85e-10 | 42 | 142 | 8 | CID000024008 | |
| Drug | MgCl2 | TPM3 MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 SPAM1 PUS3 MYH7B SPTAN1 TUBA3E ADCY9 DHX15 SARS1 | 7.67e-10 | 354 | 142 | 16 | CID000024584 |
| Drug | formycin triphosphate | 9.53e-10 | 51 | 142 | 8 | CID000122274 | |
| Drug | oxovanadium | 4.19e-09 | 120 | 142 | 10 | CID000024411 | |
| Drug | 2bq7 | 5.33e-09 | 123 | 142 | 10 | CID006540267 | |
| Drug | NSC107658 | TPM3 MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH7B SPTAN1 TUBA3E F3 KLHL20 FGL2 | 8.00e-09 | 306 | 142 | 14 | CID000002919 |
| Drug | S-(-)-Etomoxir | 1.30e-08 | 100 | 142 | 9 | CID000060765 | |
| Drug | clenbuterol | 2.13e-08 | 142 | 142 | 10 | CID000002783 | |
| Drug | NSC339663 | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH7B TUBA3E SVIL SYNE2 EEA1 | 5.82e-08 | 250 | 142 | 12 | CID000003892 |
| Drug | SM-2 | 7.24e-08 | 87 | 142 | 8 | CID000486033 | |
| Drug | AC1LADJ6 | 1.28e-07 | 130 | 142 | 9 | CID000486032 | |
| Drug | AC1NRBPQ | 2.02e-07 | 137 | 142 | 9 | CID005288569 | |
| Drug | blebbistatin | 6.77e-07 | 116 | 142 | 8 | CID003476986 | |
| Drug | B0683 | 7.22e-07 | 117 | 142 | 8 | CID006398969 | |
| Drug | carvedilol | 7.91e-07 | 161 | 142 | 9 | CID000002585 | |
| Drug | nocodazole | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH7B ARFGEF1 TUBA3E NDC80 EEA1 GOLGB1 PCNT | 1.81e-06 | 477 | 142 | 14 | CID000004122 |
| Drug | NSC226080 | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 RAPGEF6 ARID4A MYH7B IFI44 PSMD1 TSC1 SLC7A6 F3 EIF4G1 NFX1 GOLGB1 | 1.88e-06 | 782 | 142 | 18 | CID000005040 |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 2.19e-06 | 182 | 142 | 9 | 3630_DN | |
| Drug | AC1L1IZ2 | 3.39e-06 | 304 | 142 | 11 | CID000004795 | |
| Drug | creatine | 3.55e-06 | 193 | 142 | 9 | CID000000586 | |
| Drug | candesartan cilexetil | 3.64e-06 | 145 | 142 | 8 | CID000002540 | |
| Drug | AC1N9ZZC | 4.46e-06 | 149 | 142 | 8 | CID004369374 | |
| Drug | 4-chloroaniline | 5.15e-06 | 202 | 142 | 9 | CID000007812 | |
| Drug | trifluoperazine | 6.23e-06 | 324 | 142 | 11 | CID000005566 | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 1.64e-05 | 178 | 142 | 8 | 3998_DN | |
| Drug | Fibrin | 1.94e-05 | 9 | 142 | 3 | CID000439199 | |
| Drug | N-ethylmaleimide | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH7B SPTAN1 SLC7A6 ADCY9 PTPRA GOLGB1 | 1.97e-05 | 511 | 142 | 13 | CID000004362 |
| Drug | eye gene | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH7B IFI44 ADCY9 GUCY1B1 | 2.10e-05 | 369 | 142 | 11 | CID000004782 |
| Drug | Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 2.43e-05 | 188 | 142 | 8 | 4845_DN | |
| Drug | Methantheline bromide [53-46-3]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.83e-05 | 192 | 142 | 8 | 6254_DN | |
| Drug | Pimethixene maleate [13187-06-9]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 3.05e-05 | 194 | 142 | 8 | 7468_DN | |
| Drug | aspirin, USP; Up 200; 100uM; MCF7; HT_HG-U133A | 3.40e-05 | 197 | 142 | 8 | 6964_UP | |
| Drug | Chlorpromazine hydrochloride [69-09-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 3.40e-05 | 197 | 142 | 8 | 5493_DN | |
| Drug | Niridazole [61-57-4]; Down 200; 18.6uM; PC3; HT_HG-U133A | 3.52e-05 | 198 | 142 | 8 | 4621_DN | |
| Drug | STOCK1N-28457; Up 200; 20uM; MCF7; HT_HG-U133A | 3.65e-05 | 199 | 142 | 8 | 6869_UP | |
| Drug | Helioseal | 1.25e-04 | 16 | 142 | 3 | CID000122022 | |
| Drug | AC1NUTIF | 1.25e-04 | 16 | 142 | 3 | CID005492840 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 5.81e-21 | 10 | 133 | 9 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 5.81e-21 | 10 | 133 | 9 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 5.81e-21 | 10 | 133 | 9 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 5.81e-21 | 10 | 133 | 9 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 5.81e-21 | 10 | 133 | 9 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 5.81e-21 | 10 | 133 | 9 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 5.81e-21 | 10 | 133 | 9 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 5.81e-21 | 10 | 133 | 9 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 1.27e-19 | 12 | 133 | 9 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.27e-19 | 12 | 133 | 9 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 4.11e-19 | 13 | 133 | 9 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 2.85e-18 | 15 | 133 | 9 | DOID:0050646 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 8.44e-13 | 48 | 133 | 9 | DOID:423 (implicated_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 3.43e-11 | 71 | 133 | 9 | DOID:0050700 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 1.03e-10 | 80 | 133 | 9 | DOID:12930 (implicated_via_orthology) | |
| Disease | Left ventricular noncompaction | 3.14e-05 | 14 | 133 | 3 | C1960469 | |
| Disease | 4-acetamidobutanoate measurement | 4.80e-05 | 16 | 133 | 3 | EFO_0021003 | |
| Disease | Cardiomyopathy, Familial Hypertrophic, 1 (disorder) | 1.20e-04 | 4 | 133 | 2 | C3495498 | |
| Disease | Hypertrophic cardiomyopathy 1 | 1.20e-04 | 4 | 133 | 2 | cv:C3495498 | |
| Disease | Caveolinopathy | 1.20e-04 | 4 | 133 | 2 | cv:C5679790 | |
| Disease | CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1 | 1.20e-04 | 4 | 133 | 2 | 192600 | |
| Disease | asthma, response to diisocyanate | 1.89e-04 | 261 | 133 | 7 | EFO_0006995, MONDO_0004979 | |
| Disease | Congenital myopathy with fiber type disproportion | 2.99e-04 | 6 | 133 | 2 | cv:C0546264 | |
| Disease | Disproportionate short stature | 4.14e-04 | 77 | 133 | 4 | C0878659 | |
| Disease | Idiopathic hypertrophic subaortic stenosis | 4.17e-04 | 7 | 133 | 2 | C0700053 | |
| Disease | Obstructive asymmetric septal hypertrophy | 4.17e-04 | 7 | 133 | 2 | C0597124 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 4.17e-04 | 7 | 133 | 2 | C0751337 | |
| Disease | Epilepsy, Cryptogenic | 5.26e-04 | 82 | 133 | 4 | C0086237 | |
| Disease | Awakening Epilepsy | 5.26e-04 | 82 | 133 | 4 | C0751111 | |
| Disease | Aura | 5.26e-04 | 82 | 133 | 4 | C0236018 | |
| Disease | creatinine measurement | CAPN12 DENND5B GTPBP4 ZFAT BRIP1 MYH7B WBP1L PSMD1 PLXNB2 SVIL ANKRD11 PARD3 MBD5 | 5.78e-04 | 995 | 133 | 13 | EFO_0004518 |
| Disease | osteoarthritis, hand | 6.22e-04 | 37 | 133 | 3 | EFO_1000789 | |
| Disease | Distal arthrogryposis | 7.11e-04 | 9 | 133 | 2 | cv:C0265213 | |
| Disease | Cardiomyopathy, Hypertrophic, Familial | 7.11e-04 | 9 | 133 | 2 | C0949658 | |
| Disease | Paroxysmal atrial fibrillation | 7.23e-04 | 156 | 133 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 7.23e-04 | 156 | 133 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 7.23e-04 | 156 | 133 | 5 | C2585653 | |
| Disease | colorectal cancer (is_marker_for) | 7.44e-04 | 157 | 133 | 5 | DOID:9256 (is_marker_for) | |
| Disease | Atrial Fibrillation | 8.10e-04 | 160 | 133 | 5 | C0004238 | |
| Disease | Muscular dystrophy, limb-girdle, autosomal dominant | 8.86e-04 | 10 | 133 | 2 | cv:C5675009 | |
| Disease | Familial dilated cardiomyopathy | 1.04e-03 | 44 | 133 | 3 | C0340427 | |
| Disease | Acute Promyelocytic Leukemia | 1.18e-03 | 46 | 133 | 3 | C0023487 | |
| Disease | suntan | 1.24e-03 | 103 | 133 | 4 | EFO_0004279 | |
| Disease | Cardiomyopathy | 1.26e-03 | 47 | 133 | 3 | cv:C0878544 | |
| Disease | urgency urinary incontinence | 1.29e-03 | 12 | 133 | 2 | EFO_0006865 | |
| Disease | serum albumin measurement | 1.49e-03 | 592 | 133 | 9 | EFO_0004535 | |
| Disease | mean corpuscular hemoglobin concentration | MYH2 FLOT2 ZFAT BRIP1 ARID4A LRSAM1 F3 ADCY9 ALDH1A2 KIAA1217 MACF1 PRDM16 GOLGB1 | 1.50e-03 | 1105 | 133 | 13 | EFO_0004528 |
| Disease | atrial fibrillation | 1.51e-03 | 371 | 133 | 7 | EFO_0000275 | |
| Disease | Autosomal Dominant Myotubular Myopathy | 1.52e-03 | 13 | 133 | 2 | C3661489 | |
| Disease | Centronuclear myopathy | 1.52e-03 | 13 | 133 | 2 | C0175709 | |
| Disease | X-linked centronuclear myopathy | 1.52e-03 | 13 | 133 | 2 | C0410203 | |
| Disease | Myopathy, Centronuclear, 1 | 1.52e-03 | 13 | 133 | 2 | C4551952 | |
| Disease | Congenital Structural Myopathy | 1.52e-03 | 13 | 133 | 2 | C0752282 | |
| Disease | Epilepsy | 1.52e-03 | 109 | 133 | 4 | C0014544 | |
| Disease | pulse pressure measurement | FLOT2 MYH6 ZFAT DYNC2H1 WBP1L UBAP1 PLXNB2 LUZP1 DHX15 KIAA1217 ANKRD11 MBD5 PRDM16 OBI1 HYDIN | 1.56e-03 | 1392 | 133 | 15 | EFO_0005763 |
| Disease | Ciliopathies | 1.57e-03 | 110 | 133 | 4 | C4277690 | |
| Disease | Myopathy, Centronuclear, Autosomal Dominant | 1.77e-03 | 14 | 133 | 2 | C1834558 | |
| Disease | Tubular Aggregate Myopathy | 1.77e-03 | 14 | 133 | 2 | C0410207 | |
| Disease | testosterone measurement | STARD13 GTPBP4 MYH2 WBP1L CAST CCDC85C UBAP1 NME9 SCGN ADCY9 SERPINB8 SYNE2 MACF1 USP48 | 1.88e-03 | 1275 | 133 | 14 | EFO_0004908 |
| Disease | Autosomal Recessive Centronuclear Myopathy | 2.04e-03 | 15 | 133 | 2 | C3645536 | |
| Disease | Hypertrophic Cardiomyopathy | 2.19e-03 | 57 | 133 | 3 | C0007194 | |
| Disease | cutaneous melanoma | 2.23e-03 | 121 | 133 | 4 | EFO_0000389 | |
| Disease | hemoglobin A1 measurement | 2.53e-03 | 520 | 133 | 8 | EFO_0007629 | |
| Disease | level of Sphingomyelin (d32:1) in blood serum | 2.62e-03 | 17 | 133 | 2 | OBA_2045173 | |
| Disease | Familial Progressive Myoclonic Epilepsy | 2.62e-03 | 17 | 133 | 2 | C0751777 | |
| Disease | Atypical Inclusion-Body Disease | 2.62e-03 | 17 | 133 | 2 | C0751776 | |
| Disease | Myoclonic Epilepsies, Progressive | 2.62e-03 | 17 | 133 | 2 | C0751778 | |
| Disease | Biotin-Responsive Encephalopathy | 2.62e-03 | 17 | 133 | 2 | C0751780 | |
| Disease | May-White Syndrome | 2.62e-03 | 17 | 133 | 2 | C0751782 | |
| Disease | Dentatorubral-Pallidoluysian Atrophy | 2.62e-03 | 17 | 133 | 2 | C0751781 | |
| Disease | hypertension | 2.75e-03 | 307 | 133 | 6 | EFO_0000537 | |
| Disease | Congenital Fiber Type Disproportion | 2.94e-03 | 18 | 133 | 2 | C0546264 | |
| Disease | Action Myoclonus-Renal Failure Syndrome | 2.94e-03 | 18 | 133 | 2 | C0751779 | |
| Disease | reticulocyte measurement | TPM3 FLOT2 UBAP1 ECPAS PLXNB2 PTPRA SYNE2 EIF4G1 SPDYE3 MYH15 USP48 PRDM16 | 2.95e-03 | 1053 | 133 | 12 | EFO_0010700 |
| Disease | Headache | 3.05e-03 | 64 | 133 | 3 | HP_0002315 | |
| Disease | skin sensitivity to sun | 3.28e-03 | 19 | 133 | 2 | EFO_0004795 | |
| Disease | hydrocephalus (implicated_via_orthology) | 3.28e-03 | 19 | 133 | 2 | DOID:10908 (implicated_via_orthology) | |
| Disease | mean reticulocyte volume | TPM3 FLOT2 ZFAT BRIP1 SPDYE12 ADCY9 PTPRA KIAA1217 PRDM16 GOLGB1 | 3.41e-03 | 799 | 133 | 10 | EFO_0010701 |
| Disease | chemokine (C-C motif) ligand 27 measurement | 3.93e-03 | 70 | 133 | 3 | EFO_0008082 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 4.17e-03 | 144 | 133 | 4 | EFO_0004611, EFO_0020943 | |
| Disease | hypertrophic cardiomyopathy (is_implicated_in) | 4.39e-03 | 22 | 133 | 2 | DOID:11984 (is_implicated_in) | |
| Disease | Down syndrome (is_marker_for) | 4.39e-03 | 22 | 133 | 2 | DOID:14250 (is_marker_for) | |
| Disease | Primary familial hypertrophic cardiomyopathy | 4.39e-03 | 22 | 133 | 2 | cv:C0949658 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| REECAAKCEEDKEFT | 46 | Q02325 | |
| EEEEELKRKVEQCRD | 201 | Q6ZT62 | |
| EAVRKSREDLDVCKE | 1261 | Q8NDM7 | |
| DSEEDEEEKRCLLKL | 701 | Q8TDY4 | |
| DKEVIDCDSDEAKSI | 666 | Q8TC20 | |
| EEKSQEREETESKCD | 546 | P29374 | |
| EAGRDRKDALESCKE | 946 | Q6UB99 | |
| VLAEAKKPRIEDEEC | 131 | Q6P1J9 | |
| DEIDVKFKDVAGCEE | 301 | Q9Y4W6 | |
| VCEVQEADKADIDKA | 66 | O94788 | |
| ACEVALEEIKAETEK | 36 | Q9Y6D6 | |
| DDFDADKVVDKIDVC | 506 | P49747 | |
| IDEDQRDCKEAKEKA | 1236 | Q7Z2Y8 | |
| CDVKRIAELSEDDQK | 291 | Q9BZE4 | |
| AERDAGIREAECKKE | 186 | Q14254 | |
| CSKDEVDLDELLAAR | 366 | Q8WUY9 | |
| KTEDEELLERQREKC | 171 | Q008S8 | |
| CEESCDVKTKITREE | 61 | Q86XS5 | |
| EIDEACKRIKREVDD | 361 | O43143 | |
| EECEAGSRELKRCKE | 166 | Q9H257 | |
| DEEEKEKAECRDERR | 231 | Q99543 | |
| EKEKARCAELEEALQ | 1266 | O14578 | |
| DQLELTEDCKEETKI | 56 | Q6NXG1 | |
| TEDCKEETKIDVESL | 61 | Q6NXG1 | |
| EECRKEIEEREKKAG | 156 | P43487 | |
| EKCEQEEEKEDLERF | 856 | Q15042 | |
| EKCVKARERLELCDE | 41 | P07919 | |
| ERVSELCEKAEEKAK | 91 | Q96HT8 | |
| RKLEDECSELKRDID | 941 | P12883 | |
| KEDCDERDLLTVNRK | 711 | Q6P0N0 | |
| DCALKDARAKLDELE | 386 | Q86Y46 | |
| KEAGADDILDISKCE | 26 | Q6UWE0 | |
| AKVKREAEKETCDEF | 621 | Q9NQ38 | |
| EENREDKATIKCETS | 686 | O75335 | |
| IEACDVCLKEDDKDV | 46 | Q7L2H7 | |
| DSCEEDLSEKEKAIV | 371 | A6NKD9 | |
| EKKDCEERIFEEDQR | 716 | Q5BJE1 | |
| LCKQKSEVEEEGEEE | 91 | Q5VYM1 | |
| EIADEEKSEKEECNL | 1491 | Q5VYK3 | |
| KLEDECTELKKDIDD | 991 | A7E2Y1 | |
| VDRKLAEKDEECANL | 1621 | A7E2Y1 | |
| LEDECSELKKDIDDL | 946 | P13535 | |
| LEESVRDRCKKEFTD | 1241 | O15031 | |
| DECSELKKDIDDLEL | 951 | Q9UKX2 | |
| DIEDICISAIKEKDI | 1396 | Q96JB1 | |
| LDSEKKLEDARARCE | 351 | Q8NA70 | |
| DEIDCLQKEVEELKS | 101 | Q5W0B1 | |
| ECDEECSALERKKRL | 946 | Q12986 | |
| VEKVCDEDGEAKELD | 711 | O94854 | |
| DLKEDLDRDDCKQEA | 416 | P10070 | |
| KEGLLDVEKLECEDE | 281 | Q02153 | |
| KLEDECSELKKDIDD | 946 | P12882 | |
| DDSILCFLEVKEEDE | 1546 | Q9UKK3 | |
| VTDCEEEEREEKFRK | 26 | A7KAX9 | |
| ELLECLKEESAAKAE | 1311 | O95613 | |
| REECAAKCEEDKEFT | 46 | Q15195 | |
| READECIESEDKTLA | 106 | Q6UWY5 | |
| IKEVDSAREVKAEDC | 1176 | Q9BX63 | |
| REEQRKECYAKDDSE | 476 | Q2TAC6 | |
| EINKDCDREVEEEIK | 406 | A0JP26 | |
| IGDDIDDEKLKELFC | 206 | Q96DU9 | |
| CTALEEEEKKELRAF | 146 | O43900 | |
| DDLEVTRKKLVDDCH | 1091 | Q8NCM8 | |
| TLERERESEKLKDEC | 241 | Q15075 | |
| TECRDALLVKKEDGE | 306 | Q6ZSI9 | |
| EEDREKYRACDDLIK | 341 | Q4G0P3 | |
| CEDSLDERKIKGVIE | 151 | Q8TCB0 | |
| LIKSDEECRDLVDEA | 276 | Q9Y2M5 | |
| TAELAEADAREKDKE | 426 | O15078 | |
| KDKEDARLCEDVERK | 341 | A8MYV0 | |
| EDSCKRKKLEEELEG | 1586 | P15924 | |
| DKDLKLHCEEAELRD | 481 | Q6ZUT9 | |
| KAIEKDDCDETGIEE | 1326 | O60503 | |
| SLAEFCEEEEEEKKG | 291 | Q9NRY5 | |
| KEEKLEKCGEDDETI | 321 | P20810 | |
| ELSEDFDRSECKEKP | 371 | P20810 | |
| RCQKEFEKDKDDDEV | 846 | Q04637 | |
| EGKDEEIKRAEDLCR | 76 | Q86V48 | |
| TAEDVKADEDVTKLC | 86 | Q9P267 | |
| ETEEIKDERAKDVCP | 26 | Q14314 | |
| CSEKIKLAEEGSDED | 76 | Q8NA03 | |
| AEEEKCELKTKDDSE | 431 | Q12912 | |
| KDDVDLKQDLRCDTI | 576 | Q96J84 | |
| KADVKDTDAVDVCIA | 446 | P38567 | |
| DACSTEERKRDFEKI | 191 | O76038 | |
| CDALLDKDETDSSKD | 156 | Q96BU1 | |
| IDEAKACEALEALDE | 216 | Q8TEX9 | |
| EEREVKKACEDFEQD | 496 | Q8NG08 | |
| ELKKEEECESYTVRD | 661 | P18433 | |
| CDVADDKDRLVAVFD | 66 | Q8TEW0 | |
| EINKDCDREVEEEIK | 406 | B2RU33 | |
| EGKCKSLEDSEKVEE | 211 | O43364 | |
| EINKDCDREVEEEIK | 406 | Q86YR6 | |
| DEAILKCDAERIKLE | 111 | P49591 | |
| KCDAERIKLEAERFE | 116 | P49591 | |
| QRKKGDDSDEEDLCI | 126 | Q9Y3M8 | |
| ETKAKRDCNDTLEEE | 446 | Q9BZE2 | |
| LVRECLEKEPADKTD | 251 | Q8TEU7 | |
| ELECHLVDKAEFDDK | 1796 | O60522 | |
| KELCESLEEDYKDIE | 71 | Q96BD8 | |
| DDEEKVDERAKLSVA | 681 | O95425 | |
| ESVECKSADEDVIKV | 461 | Q14DG7 | |
| VEECRKALEDIDEKI | 3661 | Q8WXH0 | |
| KDICTAKEAALEEAE | 1616 | P21675 | |
| EDECFELKKEIDDLE | 956 | Q9Y2K3 | |
| EEKFESRLEDSCVEK | 576 | Q9HAZ2 | |
| IKRALDDDEDVKVCA | 391 | P28715 | |
| EEADALIESLCRDKD | 561 | Q99460 | |
| KRECLDESDDEPEKE | 61 | P0DUX0 | |
| KRECLDESDDEPEKE | 61 | P0DTA3 | |
| KRECLDESDDEPEKE | 61 | P0DUD1 | |
| CELEDFVEDLKKDST | 726 | Q5T5P2 | |
| KKFCKGDESLEDEER | 391 | Q53H47 | |
| ECKEKREDVKSEDED | 96 | O15266 | |
| RDLEDKSSAQCIDEK | 251 | Q96M29 | |
| KLEDECSELKKDIDD | 946 | Q9Y623 | |
| DECSELKKDIDDLEL | 946 | P11055 | |
| EDECSELKKDIDDLE | 946 | P13533 | |
| EENKELTDTCKERES | 836 | Q92922 | |
| KEELQELKCADVEDE | 776 | Q86YF9 | |
| LEELSFAEDTEECRK | 116 | P50452 | |
| LKEELDACEREFKEC | 891 | Q96JN2 | |
| KEEAKEQCGDELVAE | 1051 | Q96JN2 | |
| DCQAEREKAATLEKE | 266 | Q9NNX1 | |
| ELEEAKCRRASEKED | 1441 | Q9NRJ4 | |
| DSIEKDKEEAAISRE | 471 | Q92574 | |
| EKAEAAEAAEERLDC | 981 | Q92574 | |
| NESDLELEKKCKEDD | 151 | Q9P243 | |
| EDKDEDEKEKAACSA | 186 | Q05086 | |
| KIEEAEREAECKIAE | 71 | Q9NZ09 | |
| EREAECKIAEAEAKV | 76 | Q9NZ09 | |
| KRECLDESDDEPEKE | 61 | P0DUX1 | |
| KRECLDESDDEPEKE | 61 | A0A494C0Z2 | |
| KRECLDESDDEPEKE | 61 | P0DUD3 | |
| KRECLDESDDEPEKE | 61 | P0DUD4 | |
| KRECLDESDDEPEKE | 61 | P0DUD2 | |
| KRECLDESDDEPEKE | 126 | A6NKU9 | |
| GCKRKRECLDESDDE | 341 | A6NKU9 | |
| ALEDKVKALCAEADR | 306 | Q13813 | |
| NCKLEDKTEDGEALD | 16 | Q96K83 | |
| EREVIKSLDKCDFTE | 126 | Q969P6 | |
| DKVKECVDHLSRDED | 826 | Q7Z5K2 | |
| LCEDLKDAQAEEEIK | 986 | Q14683 | |
| ISDSEEEEEERKKKC | 61 | O43159 | |
| RKVIKDEALSDEDEC | 126 | Q86XW9 | |
| DTECDLTDEIVKDVK | 86 | P13726 | |
| ALALECERVKEDSDE | 476 | Q9BZF9 | |
| FCVLTELDVAEEKKD | 496 | Q92536 | |
| EEKDKEQRDRICSDE | 481 | Q9NPG3 | |
| DCDTRTEDKEFLHKE | 66 | P17020 | |
| EECEKTFSKDEELRE | 351 | Q96JF6 | |
| EECEKTFSKDEELRK | 736 | Q96JF6 | |
| KRECLDESDDEPEKE | 61 | A0A494C191 | |
| AREDLAALEKDCEEV | 421 | Q6PEY2 | |
| DCISEFLKEEKLEGD | 251 | Q86UV5 | |
| CSLEEEVDREKEILK | 2331 | Q6ZQQ6 | |
| FLDKDAECREELLKD | 211 | Q9NX94 | |
| EERAELAESKCSELE | 181 | P06753 | |
| EKLREEKEGSEEVTC | 201 | Q5JNZ3 | |
| SKEEEIRLKEDNCSV | 2221 | Q14789 | |
| QKIKEAEEEDEKCAS | 516 | O14777 |